ERBB2 and neoplasm: The greater proportion of tumors classifying as IC5 versus HER2-enriched was driven by 23% of IC5 tumors classifying as the normal-like intrinsic subtype, which may encompass tumors with high non-tumor cell contamination30,38, suggesting that integrative cluster assignment may be less sensitive to differences in tumor cellularity than intrinsic subtype assignment.